Table 2 Revascularization details and outcomes
All patients (n = 50) | No reperfusion Injury (n = 28) | Reperfusion injury (n = 22) | p value | |
|---|---|---|---|---|
Endovascular revascularization | ||||
Techniques | ||||
Thrombolysis | 24 (49%) | 9 (33%) | 15 (68%) | 0.02 |
Stenting | 21 (42%) | 16 (57%) | 5 (23%) | 0.01 |
Thrombus-aspiration | 20 (40%) | 6 (21%) | 14 (63%) | < 0.01 |
≥ 2 combined techniques | 18 (36%) | 6 (21%) | 12 (54%) | 0.02 |
Technical Failure | 4 (8%) | 2 (7%) | 2 (9%)§ | 0.99 |
Adverse event | 0.07 | |||
Absence | 39 (80%) | 21 (78%) | 18 (82%) | |
Mild/Moderate | 5 (10%) | 5 (18%) | 0 (-) | |
Severe | 6 (12%) | 2 (7%) | 4 (18%) | |
Follow-up CT | ||||
Delay revascularization-CT (hours)¤ | 39 (18–65) | 42 (15–71) | 28 (20–48) | 0.39 |
Indication of CT | ||||
Systematic follow-up | 24 (48%) | 13 (46%) | 11 (50%) | |
Abdominal pain | 13 (26%) | 9 (32%) | 4 (18%) | |
Clinical worsening | 3 (6%) | 1 (4%) | 2 (9%) | |
Inflammatory syndrome | 3 (6%) | 2 (7%) | 1 (5%) | |
Elevated serum lactate | 3 (6%) | 1 (4%) | 2 (9%) | |
Internal bleeding suspicion | 4 (8%) | 2 (7%) | 2 (9%) | |
SMA Recanalization | 0.49 | |||
None | 8 (16%) | 6 (21%) | 2 (9%)¥ | |
Partial | 19 (38%) | 10 (36%) | 9 (41%) | |
Complete | 23 (46%) | 12 (43%) | 11 (50%) | |
Clinical/Biological change after revascularization | ||||
Abdominal pain† | 26 (55%) | 11 (42%) | 15 (71%) | 0.07 |
Bloody diarrhea‡ | 8 (17%) | 3 (12%) | 5 (25%) | 0.26 |
Change in serum lactate (%)‡ | − 5% (− 38%; + 73%) | 0% (− 33%; + 95%) | − 6% (− 43%; + 68%) | 0.42 |
Change in WBC (%)‡ | − 6% (− 25%, + 13%) | − 5% (− 19%, + 15%) | − 9% (− 32%; + 10%) | 0.45 |
Change in CRP (%)* | + 93% (− 6%; + 408%) | + 5% (− 36%, + 171%) | + 371% (+ 100; + 495%) | < 0.01 |
Survival and morbidity | ||||
Secondary bowel resection | 9 (18%) | 2 (7%) | 7 (32%) | 0.03 |
Mean resected bowel length (cm) | 80 (46–100) | 48 (16–80) | 80 (46–115) | 0.33 |
3-month survival | 38 (76%) | 22 (79%) | 16 (73%) | 0.74 |